Cargando…
Antiphospholipid syndrome: a clinical perspective
Antiphospholipid syndrome (APS) is a thromboinflammatory disease with a variety of clinical phenotypes. Primary thrombosis prophylaxis should take an individualized risk stratification approach. Moderate-intensity vitamin K antagonist such as warfarin remains the primary strategy for secondary throm...
Autores principales: | Zuo, Yu, Shi, Hui, Li, Chun, Knight, Jason S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176446/ https://www.ncbi.nlm.nih.gov/pubmed/32265421 http://dx.doi.org/10.1097/CM9.0000000000000705 |
Ejemplares similares
-
Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome
por: Knight, Jason S., et al.
Publicado: (2022) -
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series
por: Madison, Jacqueline A., et al.
Publicado: (2022) -
Antiphospholipid syndrome
por: Espinosa, Gerard, et al.
Publicado: (2008) -
Clinical Management of Thrombotic Antiphospholipid Syndrome
por: Tumian, Nor Rafeah, et al.
Publicado: (2022) -
Management of Antiphospholipid Syndrome
por: Ghembaza, Amine, et al.
Publicado: (2020)